NEW YORK (360Dx) – Metabolomic Diagnostics said on Tuesday that it has secured €2 million ($2.4 million) in European Union funding under the Horizon 2020 SME Instrument, an initiative to accelerate growth in small- and medium-size companies.

The Cork, Ireland-based biotech firm said it will use the funds to commercialize its PrePsia blood test for women in early pregnancy to detect whether they could develop preterm preeclampsia.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.